Belgian AI Drug Discovery Startup Sightera Biosciences Secures €3 Million Pre-Seed Funding
Belgian tech‑bio startup Sightera Biosciences raised €3 million in a pre‑seed round led by Entourage, with participation from Anacura and QBIC, to scale its AI‑native platform that uses patient‑derived samples for oncology and fibrosis drug discovery.